Dermavon Holdings Limited
Clinical trials sponsored by Dermavon Holdings Limited, explained in plain language.
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called CMS-D001 in 160 adults with moderate to severe atopic dermatitis (eczema) who haven't responded well to standard creams. The goal is to see if the drug can reduce skin redness, itching, and rash by at least 75%. Participants will recei…
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 26, 2026 10:15 UTC
-
New psoriasis pill shows promise in major trial
Disease control Not yet recruitingThis study tests a new tablet called CMS-D001 for adults with moderate to severe plaque psoriasis. About 540 people will take either the drug or a placebo to see if it improves skin symptoms like redness and scaling. The goal is to find a safe and effective treatment option.
Phase: PHASE2, PHASE3 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 11, 2026 20:47 UTC